Literature DB >> 43981

MIF-I's differential actions as an opiate antagonist.

A J Kastin, R D Olson, R H Ehrensing, M C Berzas, A V Schally, D H Coy.   

Abstract

The effects of MIF-I (Pro-Leu-Gly-NH2) were examined in three experimental conditions in which the opiate antagonist naloxone is active. MIF-I was found to block the analgesic effects of enkephalins and also morphine in the tail-flick test but not in the vas deferens assay. Unlike naloxone, MIF-I did not seem to reduce food intake in VMH-lesioned rats. The results suggest the possibility that MIF-I may represent a class of naturally occurring opiate antagonists with varying activities in independent situations.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 43981     DOI: 10.1016/0091-3057(79)90270-3

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  5 in total

Review 1.  Concepts for biologically active peptides.

Authors:  Abba J Kastin; Weihong Pan
Journal:  Curr Pharm Des       Date:  2010-10       Impact factor: 3.116

2.  Tyr-MIF-1 attenuates antinociceptive responses induced by three models of stress-analgesia.

Authors:  Z H Galina; A J Kastin
Journal:  Br J Pharmacol       Date:  1987-04       Impact factor: 8.739

3.  Isolation, sequencing, synthesis, and pharmacological characterization of two brain neuropeptides that modulate the action of morphine.

Authors:  H Y Yang; W Fratta; E A Majane; E Costa
Journal:  Proc Natl Acad Sci U S A       Date:  1985-11       Impact factor: 11.205

4.  Brain Activation by Peptide Pro-Leu-Gly-NH(2) (MIF-1).

Authors:  Reas S Khan; Chuanhui Yu; Abba J Kastin; Yi He; Rudolph H Ehrensing; Hung Hsuchou; Kirsten Prufer Stone; Weihong Pan
Journal:  Int J Pept       Date:  2010-03-28

Review 5.  Crosstalk between Opioid and Anti-Opioid Systems: An Overview and Its Possible Therapeutic Significance.

Authors:  Ewa Gibula-Tarlowska; Jolanta H Kotlinska
Journal:  Biomolecules       Date:  2020-09-28
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.